Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 09:08:09 17/09/2026 BST			5-day change	1st Jan Change
8.850 ^HKD	+0.51%		-2.75%	+4.98%

09-16	CSPC Pharmaceutical Group Limited Initiates Phase II Clinical Trial Of SYH2069 Injection For Treatment Of Type 2 Diabetes Mellitus In Adult Patients At First Centre In China	CI
09-16	Pharma sector doubles down on AI to slash costs, timelines	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	101,182	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	4.98%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	89,965	86,897	83,756
Change	-	-3.79%	-16.18%	-35.07%	84.76%	3.75%	-3.41%	-3.61%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	9.87x	14.8x	13.8x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.26x	2.12x	1.96x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0x	-0.4x	2.02x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.63x	2.84x	2.68x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.33x	2.44x	2.22x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.53x	9.18x	7.92x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	7.35x	10.9x	10x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	11.8x	13.1x	12.1x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	8.49%	7.64%	8.24%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.445	0.364	0.388
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	5.03%	4.11%	4.38%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.8966	0.5985	0.6395
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	49.6%	60.8%	60.7%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	38,531	35,635	37,809
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	13,782	9,467	10,580
EBIT ¹	8,366	7,952	7,400	6,113	5,564	12,245	7,936	8,376
Net income ¹	6,901	6,949	6,382	4,632	4,409	10,227	6,976	7,478
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-11,217	-14,285	-17,426
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.850	8.850	8.850
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	9.82x	2.32x	6.49x	5.05%	12.83B
ELI LILLY AND COMPANY	32.35x	11.76x	23.85x	0.61%	1,014B
JOHNSON & JOHNSON	29.73x	6.61x	18.52x	2.01%	644B
ABBVIE INC.	33.2x	7.77x	16.07x	2.61%	464B
ROCHE HOLDING AG	19.64x	4.8x	11.88x	2.76%	354B
NOVARTIS AG	19.71x	5.15x	12.77x	3.12%	265B
ASTRAZENECA PLC	20.89x	4.31x	12.32x	2.04%	253B
AMGEN INC.	23.89x	6.29x	11.2x	2.68%	203B
NOVO NORDISK A/S	12.12x	4.42x	9.24x	4.14%	186B
GILEAD SCIENCES, INC.	-44.67x	6.51x	25.43x	2.23%	183B
Average	15.67x	6.00x	14.78x	2.73%	357.96B
Weighted average by Cap.	23.43x	7.62x	17.60x	2.02%